Freedom of Information request on a list of the excipients in the AstraZeneca COVID-19 vaccine (FOI 21-768)
Published 27 April 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-2-august-2021/freedom-of-information-request-on-a-list-of-the-excipients-in-the-astrazeneca-covid-19-vaccine-foi-21-768
3rd August 2021 FOI 21/768
Dear
A list of the excipients in the AstraZeneca can be found at the following link: Summary of Product Characteristics for Vaxzevria - GOV.UK (www.gov.uk)
Please note that the bovine growth hormone polyA tail is a nucleotide sequence from a bovine growth hormone gene. There is no bovine growth hormone in the AZ COVID-19 vaccine.
The structure of the gene construct encoded in the AZD1222 genome is shown in Figure 1 of the European Public Assessment Report (Page 16) available at this link: https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf
Many thanks,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000